What Is hCG? Alpha and Beta Subunits, Glycosylation and IU Explained

What procurement and laboratory teams should review

Define the molecular form before comparing offers

Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.

• Record sequence, termini and every modification explicitly.
• State the requested salt or counterion form.
• Treat solubility and stability as material- and condition-specific.

hCG is an alpha-beta glycoprotein pair

Human chorionic gonadotropin is assembled from two different polypeptide chains called the alpha and beta subunits. They associate non-covalently, meaning the intact hormone is held together by molecular interactions rather than a peptide bond joining the two chains.

UniProt describes the beta chain as part of a complex glycoprotein composed of glycosylated alpha and beta subunits. Structural studies further show that both chains are disulfide-rich and adopt cystine-knot folds. This makes intact hCG closer to a complex glycoprotein biologic than to a short synthetic peptide.

Why beta-hCG is specific but alpha-hCG is shared

The alpha subunit is common to hCG and the pituitary glycoprotein hormones LH, FSH and TSH. Their beta subunits differ and provide much of the receptor and immunological specificity. That is why many analytical or diagnostic discussions focus on beta-hCG or beta-subunit-specific epitopes.

Intact hCG, free beta-hCG and free alpha subunit are not interchangeable analytes. An antibody that recognizes one form may not quantify another in the same way. A research plan should name the intended form rather than use HCG as an all-purpose label.

• Intact hCG: associated alpha-beta heterodimer
• Free beta-hCG: unpaired beta subunit
• Free alpha subunit: shared glycoprotein-hormone chain
• Fragments or nicked forms: structurally altered analytes

Glycosylation creates real molecular diversity

Glycosylation means carbohydrate chains are attached to defined amino-acid sites. hCG contains both N-linked and, on its beta subunit, O-linked carbohydrate structures. The attached glycans contribute substantially to apparent molecular mass, charge and separation behavior.

Glycans are not represented by the amino-acid sequence alone and can vary with biological source and recombinant expression system. Two samples can share the same polypeptide backbone while differing in glycan distribution. Consequently, a single intact-mass number or peptide HPLC trace cannot fully describe hCG heterogeneity.

IU and milligrams answer different questions

A milligram is a unit of mass. An International Unit, or IU, represents an assigned amount of biological activity defined through a reference system and assay. There is no universal equation that converts every hCG IU value into milligrams independently of the material and assigned potency.

For example, two preparations with the same gross mass may contain different amounts of intact, correctly assembled material or may receive different potency assignments. Likewise, an IU claim does not reveal purity, glycosylation, free-subunit content or container mass. A research document should state the reference, assay and calculation behind the unit.

• mg: how much material by mass
• IU: assigned biological activity
• HPLC area percent: method-specific chromatographic composition
• Protein assay: quantitative result dependent on method and standard

What evidence fits an hCG research sample

Identity work may need to demonstrate both subunits and intact assembly. Depending on the question, laboratories may use electrophoresis, immunochemical methods, peptide mapping, size-based separation or mass spectrometry. Glycan-sensitive or charge-variant methods may be appropriate when heterogeneity is important.

A biological potency assay addresses a different quality attribute from molecular identity or purity. The results should be interpreted with a suitable reference standard and method controls. Research-grade labeling does not imply sterility, regulatory approval, equivalence to a named medicine or suitability for administration.

• Intact versus free-subunit definition
• Source and expression system
• Glycosylation or charge-variant scope
• Lot-specific identity, purity and potency records

Questions to resolve before quotation or release

1. Is the target intact heterodimer or beta-hCG alone?
2. What source and glycosylation context apply?
3. How was an IU value assigned and against which reference?